Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer Symposium | Business Wire
Aprendo para enseñar... enseño para VIVIR: Mafalda y la PUMA mayor fueron al estadio Olimpico,